World leader in probiotics
BioGaia is an innovative Swedish health care company and a world leader in probiotics with more than 25 years experience of developing, marketing and selling probiotic products. Over the years we have created global networks of leading, independent researchers and specialists, manufacturing experts and local distribution partners worldwide.
More than 25 years experience in the field of probiotics
BioGaia’s products are sold in around 90 countries. The largest segment is paediatrics, accounting for over 80 per cent of total sales. Our focus is on finished consumer products that are sold under our own BioGaia brand. In 2015 these sales, including co-branding, accounted for over 60 per cent of sales of finished consumer products. The strategy is to continuously increase the share of products sold under the BioGaia brand.
Our products combine the well researched probiotic bacteria Lactobacillus reuteri with top of the line engineering to develop unique packaging solutions and create probiotic products that match consumer needs. Lactobacillus reuteri is a “good” and friendly bacterium that helps battle the “bad” microorganisms in the digestive tract.
Headquarters, with executive management, administrative functions and marketing and sales are based in Stockholm. Product development and departments for production and quality control are based in Lund. Sales offices are also based in Tokyo and Hiroshima.
The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.
BioGaia’s business model is based on three external networks – research, production and distribution. In the research area there are collaborations with more than 50 research institutions and clinics. The products are manufactured and packaged at six different facilities in Europe and the USA. The distribution network consists of around 60 partners with sales in some 90 countries.